Inovio Pharmaceuticals unveils potent new immune activator
1/24/2014
Inovio Pharmaceuticals, Inc. has unveiled that the company has developed a new DNA-based cytokine immune activator, interleukin -33 (IL-33), that in combination with optimized DNA vaccines delivered by electroporation increased the potency and efficacy of the therapeutic response to the DNA vaccines in a preclinical study.
Metastatic melanoma has a poor prognosis, but treatment with high-dose interleukin-2 (IL2) can extend survival.
Idelalisib shows promise in treating indolent non-Hodgkin lymphomas
1/24/2014
Slow-growing, or indolent, non-Hodgkin lymphomas are difficult to treat, with most patients relapsing repeatedly and the disease becoming increasingly resistant to therapy over time.But a new drug made by Seattle-based Gilead Sciences Inc.
Blood-forming stem cell function promoted by estrogen
1/24/2014
Scientists have known for years that stem cells in male and female sexual organs are regulated differently by their respective hormones.
Patterns of cancer screening in Appalachian women examined
1/24/2014
A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.Published in Women & Health, the study focused on six rural counties in Appalachian Kentucky.
Patterns of cancer screening in Appalachian women examined
1/24/2014
A new study by University of Kentucky researchers shows that women who never or rarely screen for breast cancer are also unlikely to receive screening for cervical cancer. The study also identified four key barriers independently associated with the lack of these cancer screenings in Appalachian women.Published in Women & Health, the study focused on six rural counties in Appalachian Kentucky.
Outcome in HPV-related oral cancers not necessarily predicted by number of cancer stem cells
1/24/2014
New research from The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that it may be the quality of cancer stem cells rather than their quantity that leads to better survival in certain patients with oral cancer.
Computer model simulates blood vessel growth
1/24/2014
University of Utah bioengineers showed that tiny blood vessels grow better in the laboratory if the tissue surrounding them is less dense. Then the researchers created a computer simulation to predict such growth accurately - an early step toward treatments to provide blood supply to tissues damaged by diabetes and heart attacks and to skin grafts and implanted ligaments and tendons.
'Liquid biopsy' a potential test for bladder cancer
1/24/2014
Findings from a Loyola University Medical Center study ultimately could lead to tests to screen for and diagnose bladder cancer.Bladder cancer is the fourth most common non-skin cancer. But there is no good screening test for it, and there has been limited progress in characterizing how aggressive an individual's bladder cancer will be.
Window into living cells provided by 3-D imaging, no dye required
1/24/2014
Living cells are ready for their close-ups, thanks to a new imaging technique that needs no dyes or other chemicals, yet renders high-resolution, three-dimensional, quantitative imagery of cells and their internal structures - all with conventional microscopes and white light.